Nymox Pharmaceutical Corp (NASDAQ:NYMX)

0.6275
Delayed Data
As of 3:48pm ET
 +0.0375 / +6.36%
Today’s Change
0.33
Today|||52-Week Range
5.76
+56.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues937.5K732.6K752.3K735.5K
 
 
 
 
 
Cost of Goods Sold226.5K57.0K48.2K45.4K
 
 
 
 
 
Depreciation And Amortization2.4K1.5K1.5K1.9K
 
 
 
 
 
 
Operating ExpensesGross Income708.6K674.0K702.5K688.2K
 
 
 
 
 
General Expenses2.1M3.4M1.6M1.4M
 
 
 
 
 
Research And Development1.7M2.1M1.1M897.5K
 
 
 
 
 
Total Operating Expenses2.4M3.4M1.6M1.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.4M-2.7M-860.7K-734.3K
 
 
 
 
 
Other Expenses-3.1K-8.8K-44.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.4M-2.7M-904.7K-725.0K
 
 
 
 
 
Income Taxes-101.7K-96.4K-84.4K-36.8K
 
 
 
 
 
Net Income-1.3M-2.6M-820.3K-688.2K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS32.9M34.8M35.1M35.4M
 
 
 
 
 
Shares To Calculate EPS Diluted32.9M34.8M35.1M35.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.04-$0.07-$0.02-$0.02
 
 
 
 
 
EPS Diluted-$0.04-$0.07-$0.02-$0.02
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account